Clinical Trials for MPDL3280A
1 Open Trial
| Trial Type | Protocol No. & Open Date | Summary |
|---|---|---|
| Therapeutic | VICCPHI1138 03/08/2012 | A Phase I, Open-Label, Dose-Escalation study of the safety and Pharmacokinetics of MPDL3280A administered intravenously as a single agent to patients with locally advanced or metastatic solid tumors. |
You do not have JavaScript enabled. This site works better with JavaScript turned on.
